1. Assessment of the Hematopoietic Cell Transplantation Comorbidity Index in Non- Hodgkin Lymphoma Patients Receiving Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation 
Seth M. Pollack, Seth M. Steinberg, Jeanne Odom, Robert M. Dean, Daniel H. Fowler, Michael R. Bishop 
Biology of Blood and Marrow Transplantation 
Volume 15, Issue 2, Pages (February 2009)
DOI: /j.bbmt
Copyright © 2009 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Transplantation outcomes in patients (n = 63) undergoing reduced-intensity allogeneic HSCT. (A) Cumulative incidences of TRM and DRM. (B) Probability of OS.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2009 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Impact of HCT-CI on transplantation outcome: (A) TRM; (B) DRM; (C) OS.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2009 American Society for Blood and Marrow Transplantation Terms and Conditions